The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 2, 2005, Pages 197-203

  Nachtigal, Petr ^a   Kopecky, Martin ^a   Solichova, Dagmar ^b   Zdansky, Petr ^b   Semecky, Vladimir ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PADGEM PROTEIN; SIMVASTATIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RABBIT; RANDOMIZATION; STEREOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; AORTA, THORACIC; ARTERIOSCLEROSIS; CAROTID ARTERIES; CELL ADHESION MOLECULES; CHOLESTEROL; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RABBITS; SIMVASTATIN; TIME FACTORS;

EID: 12344283682     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055353     Document Type: Article

References (35)

1. Aikawa, M., Sugiyama, S., Hill, C. C., Voglic, S. J., Rabkin, E., Fukumoto, Y., Schoen, F. J., Witztum, J. L., Libby, P. (2002) Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation 106: 1390-1396
2. Alfon, J., Guasch, J. F., Berrozpe, M., Badimon, L. (1999) Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors. Atherosclerosis 145: 325-331
3. Behr, D., Rupin, A., Fabiani, J. N., Verbeuren, T. J. (1999) Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis 142: 335-344
4. Behr-Roussel, D., Rupin, A., Simonet, S., Bonhomme, E., Coumailleau, S., Cordi, A., Serkiz, B., Fabiani, J. N., Verbeuren, T. J. (2000) Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 102: 1033-1038
5. Blann, A. D., McCollum, C. N. (1994) Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb. Haemost. 72: 151-154
6. Ceriello, A., Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Esposito, K., Giugliano, D. (2004) Effect of post-prandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53: 701-710
7. Cybulsky, M. I., Lichtman, A. H., Hajra, L., Iiyama, K. (1999) Leukocyte adhesion molecules in atherogenesis. Clin. Chim. Acta 286: 207-218
8. Esaki, T., Hayashi, T., Muto, E., Yamada, K., Kuzuya, M., Iguchi, A. (1997) Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis 128: 39-46
9. Gundersen, H. J., Bagger, P., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., Moller, A., Nielsen, K., Nyengaard, J. R., Pakkenberg, B. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96: 857-881
10. Hoshida, S., Yamashita, N., Kawahara, K., Kuzuya, T., Hori, M. (1999) Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms. Circulation 99: 434-440
11. Hotta, Y., Otsuka-Murakami, H., Fujita, M., Nakagawa, J., Yajima, M., Liu, W., Ishikawa, N., Kawai, N., Masumizu, T., Kohno, M. (1999) Protective role of nitric oxide synthase against ischemia-reperfusion injury in guinea pig myocardial mitochondria. Eur. J. Pharmacol. 380: 37-48
12. Jang, Y., Lincoff, A. M., Plow, E. F., Topol, E. J. (1994) Cell adhesion molecules in coronary artery disease. J. Am. Coll. Cardiol. 24: 1591-1601
13. Koh, K. K, Son, J. W, Ahn, J. Y., Jin, D. K., Kirn, H. S., Choi, Y. M., Ahn, T. H., Kim, D. S., Shin, E. K. (2004) Vascular effects of diet and statin in hypercholesterolemic patients. Int. J. Cardiol. 95: 185-191
14. Kolyada, A. Y., Fedtsov, A., Madias, N. E. (2001) 3-Hydroxy-3- methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells. Hypertension 38: 1024-1029
15. Krieglstein, C. F., Granger, D. N. (2001) Adhesion molecules and their role in vascular disease. Am. J. Hypertens. 14: 44S-54S
16. Laufs, U., La Fata, V., Plutzky, J., Liao, J. K. (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135
17. Mark, L., Katona, A. (2000) [The effects of statins on stroke and cardiovascular incidence in randomized, placebo-controlled trials with clinical endpoints]. Orv. Hetil. 141: 1501-1505
18. Martin Lujan, F., Baldrich Justel, M., Sola Alberich, R., Basora Gallisa, J. (2004) [About cardiovascular risk assessment in the new clinical trials with statins]. Med. Clin. (Barc.) 122: 559
19. Nachtigal, P., Semecky, V., Gojova, A., Kopecky, M., Benes, V., Juzkova, R. (2002) The application of stereological methods for the quantitative analysis of the atherosclerotic lesions in rabbits. Image Anal. Stereol. 21: 165-174
20. Nachtigal, P., Semecky, V., Kopecky, M., Gojova, A., Solichova, D., Zdansky, P., Zadak, Z. (2004) Application of stereological methods for the quantification of VCAM-1 and ICAM-1 expression in early stages of rabbit atherogenesis. Pathol. Res. Pract. 200: 219-229
21. O'Brien, K. D., McDonald, T. O., Chait, A., Alien, M. D., Alpers, C. E. (1996) Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93: 672-682
22. Price, D. T., Loscalzo, J. (1999) Cellular adhesion molecules and atherogenesis. Am. J. Med. 107: 85-97
23. Pruefer, D., Scalia, R., Lefer, A. M. (1999) Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler. Thromb. Vasc. Biol. 19: 2894-2900
24. Pruefer, D., Makowski, J., Schnell, M., Buerke, U., Dahm, M., Oelert, H., Sibelius, U., Grandel, U., Grimminger, F., Seeger, W., Meyer, J., Darius, H., Buerke, M. (2002) Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 106: 2104-2110
25. Rezaie-Majd, A., Prager, G. W., Bucek, R. A., Schernthaner, G. H., Maca, T., Kress, H. G., Valent, P., Binder, B. R., Minar, E., Baghestanian, M. (2003) Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. 23: 397-403
26. Sakai, A., Kume, N., Nishi, E., Tanoue, K., Miyasaka, M., Kita, T. (1997) P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimai accumulation of macrophages and T lymphocytes. Arterioscler. Thromb. Vasc. Biol. 17: 310-316
27. Sparrow, C. P., Burton, C. A., Hernandez, M., Mundt, S., Hassing, H., Patel, S., Rosa, R., Hermanowski-Vosatka, A., Wang, P. R., Zhang, D., Peterson, L., Detmers, P. A., Chao, Y. S., Wright, S. D. (2001) Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler. Thromb. Vasc. Biol. 21: 115-121
28. Sukhova, G. K., Williams, J. K., Libby, P. (2002) Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol. Arterioscler. Thromb. Vasc. Biol. 22: 1452-1458
29. Thakur, N. K., Hayashi, T., Sumi, D., Kano, H., Tsunekawa, T., Iguchi, A. (2001) HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing Superoxide. Am. J. Physiol. Heart Circ. Physiol. 281: H75-H83
30. Toborek, M., Kaiser, S. (1999) Endothelial cell functions. Relationship to atherogenesis. Basic Res Cardiol. 94: 295-314
31. Weibel, E. (1979) Stereological methods, VoI 1. Practical methods for biology morphometry. Academic Press, London
32. White, C. R., Brock, T. A., Chang, L. Y., Crapo, J., Briscoe, P., Ku, D., Bradley, W. A., Gianturco, S. H., Gore, J., Freeman, B. A. (1994) Superoxide and peroxynitrite in atherosclerosis. Pro. Natl Acad. Sci. USA 91: 1044-1048
33. Yang, A. L., Chen, H. I. (2003) Chronic exercise reduces adhesion molecules/iNOS expression and partially reverses vascular responsiveness in hypercholesterolemic rabbit aortae. Atherosclerosis 169: 11-17
34. Zapolska-Downar, D., Siennicka, A., Kaczmarczyk, M., Kolodziej, B., Naruszewicz, M. (2004) Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells. Life Sci. 75: 1287-1302
35. Zou, Y., Hu, D., Yang, X., Xu, Z., Cui, L., Liu, X., Wei, Y., Gao, M. (2003) Lipid-lowering efficacy and safety of varying doses of simvastatin in patients with early stage acute coronary syndromes: one-year follow-up study. Chin. Med. J. (Engl.) 116: 853-856